Using Artificial Intelligence to speed Alzheimer’s studies

Share:

Saving Minds

Miscellaneous

This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research.